This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1997 Mar;99(3):476-8.

doi: 10.1542/peds.99.3.476.

The credibility of the ACTOBAT follow-up study

M C McCormick¹

Affiliations

PMID: 9041308
DOI: 10.1542/peds.99.3.476

Clinical Trial

The credibility of the ACTOBAT follow-up study

M C McCormick. Pediatrics. 1997 Mar.

. 1997 Mar;99(3):476-8.

doi: 10.1542/peds.99.3.476.

Author

M C McCormick¹

Affiliation

¹ Department of Maternal and Child Health, Harvard School of Public Health and Joint Program in Neonatology, Harvard Medical School, Boston, MA 02115, USA.

PMID: 9041308
DOI: 10.1542/peds.99.3.476

No abstract available

PubMed Disclaimer

Comment in

Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone: adverse effects at 12-month follow-up. ACTOBAT Study Group.
Crowther CA, Hiller JE, Haslam RR, Robinson JS. Crowther CA, et al. Pediatrics. 1997 Mar;99(3):311-7. doi: 10.1542/peds.99.3.311. Pediatrics. 1997. PMID: 9041281 Clinical Trial.
The ACTOBAT debate.
Crowther C. Crowther C. Pediatrics. 1997 Sep;100(3 Pt 1):418-9. doi: 10.1542/peds.100.3.418. Pediatrics. 1997. PMID: 9304109 Clinical Trial. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information